News & Updates

Serum DHEA, testosterone levels inversely linked to CAC in older men

21 Dec 2023

In older men, serum levels of dehydroepiandrosterone (DHEA) and testosterone correlate inversely with coronary artery calcification (CAC), partially independently from each other, a study has shown.

Serum DHEA, testosterone levels inversely linked to CAC in older men

21 Dec 2023

Iptacopan delivers durable responses in anti-C5-treated PNH patients with anaemia

21 Dec 2023 by

The final results of the pivotal phase III APPLY-PNH trial show sustained efficacy and safety of the oral factor B inhibitor iptacopan in anti-C5-treated patients with paroxysmal nocturnal haemoglobinuria (PNH) and persistent anaemia.

Iptacopan delivers durable responses in anti-C5-treated PNH patients with anaemia

21 Dec 2023

Noninvasive ultrasound therapy feasible in calcified aortic stenosis

21 Dec 2023

The novel, noninvasive ultrasound therapy is safe and may help improve valvular function in patients with calcified aortic stenosis, according to a study.

Noninvasive ultrasound therapy feasible in calcified aortic stenosis

21 Dec 2023

Mobocertinib only as good as platinum chemo in first-line NSCLC treatment

20 Dec 2023 by

In the first-line treatment of locally advanced or metastatic nonsmall cell lung cancer (NSCLC) patients with EGFR exon 20 insertion (ex20ins) mutations, the investigational mobocertinib is safe and efficacious but not necessarily better than platinum-based chemotherapy, according to the phase III EXCLAIM-2 trial.

Mobocertinib only as good as platinum chemo in first-line NSCLC treatment

20 Dec 2023

Long-term risankizumab safe, effective in moderate-to-severe plaque psoriasis

20 Dec 2023 by

Treatment with risankizumab in the long term shows lasting efficacy against moderate-to-severe plaque psoriasis and has good tolerability, according to the LIMMitless study.

Long-term risankizumab safe, effective in moderate-to-severe plaque psoriasis

20 Dec 2023

NAFLD ups risk of memory impairment, hippocampal damage

20 Dec 2023

The presence and severity of nonalcoholic fatty liver disease (NAFLD) may contribute to cognitive impairment, as well as hippocampal structure and functional abnormalities, suggests a study.

NAFLD ups risk of memory impairment, hippocampal damage

20 Dec 2023

Add-on ribociclib continues to triumph in early breast cancer

20 Dec 2023 by

Coming on the heels of the second interim analysis, the protocol-specified final invasive disease-free survival (iDFS) analysis of the phase III NATALEE trial continues to show a highly significant iDFS benefit with the combination of the CDK 4/6 inhibitor ribociclib and a nonsteroidal aromatase inhibitor (NSAI) in individuals with HR+/HER2- early breast cancer.

Add-on ribociclib continues to triumph in early breast cancer

20 Dec 2023

Unlocking the potential of Bacillus clausii: Breakthroughs and innovations

20 Dec 2023

Probiotics have emerged as a pivotal adjunctive therapy for managing acute diarrhea. Recent advancements have unveiled the diverse utility of these bioactive agents beyond solely addressing diarrhea. Bacillus clausii (B. clausii), a widely utilized probiotic for acute diarrhea, particularly in pediatric cases, boasts multiple attributes that underpin its current applications and prospects. This article aims to delve into Bacillus clausii's physiological, probiotic, and immunomodulatory characteristics, shedding light on its potential indications through an exploration of ongoing research.

Unlocking the potential of Bacillus clausii: Breakthroughs and innovations

20 Dec 2023

Cilostazol safe but not neuroprotective

20 Dec 2023

In the treatment of people with mild cognitive impairment, cilostazol is well tolerated but falls short of preventing further cognitive decline, according to the results of the phase II COMCID* trial.

Cilostazol safe but not neuroprotective

20 Dec 2023

Daily smoking linked to smaller brains

19 Dec 2023 by

Smoking daily may cause the brain to shrink in a dose-response manner, and quitting does not seem to reverse the brain volume loss, as reported in a study.

Daily smoking linked to smaller brains

19 Dec 2023

News & Updates

Filter by Specialty:

Specialty:

Serum DHEA, testosterone levels inversely linked to CAC in older men

Serum DHEA, testosterone levels inversely linked to CAC in older men

Iptacopan delivers durable responses in anti-C5-treated PNH patients with anaemia

Iptacopan delivers durable responses in anti-C5-treated PNH patients with anaemia

Noninvasive ultrasound therapy feasible in calcified aortic stenosis

Noninvasive ultrasound therapy feasible in calcified aortic stenosis

Mobocertinib only as good as platinum chemo in first-line NSCLC treatment

Mobocertinib only as good as platinum chemo in first-line NSCLC treatment

Long-term risankizumab safe, effective in moderate-to-severe plaque psoriasis

Long-term risankizumab safe, effective in moderate-to-severe plaque psoriasis

NAFLD ups risk of memory impairment, hippocampal damage

NAFLD ups risk of memory impairment, hippocampal damage

Add-on ribociclib continues to triumph in early breast cancer

Add-on ribociclib continues to triumph in early breast cancer

Unlocking the potential of Bacillus clausii: Breakthroughs and innovations

Unlocking the potential of Bacillus clausii: Breakthroughs and innovations

Cilostazol safe but not neuroprotective

Cilostazol safe but not neuroprotective

Daily smoking linked to smaller brains

Daily smoking linked to smaller brains